透析膜生体適合性評価におけるHPLCによる血清ネオプテリン測定の有用性 : ビタミンE固相化改質セルロース膜における基礎的・臨床的評価
史好 中辻, 龍生 米田, 頼明 影林 et al. · Nara Medical University Institutional Repository (GINMU) (Nara Medical University) · 1999
Exposure of blood to hemodialysis membranes results in numerous phenom- \nena or complications in hemodialysis (HD) patients, and these complications influence the \nquality of life (QOL) in HD patients. Vitamin E coated cellulose dialyzer (E-membrane) \nis developed to act as scavenger for reactive oxgen species which couse complications in \nHD patients.\nNeopterin (NEOP) is the metabolites derived from guanosine triphosphate. Recently it \nwas shown that production and release of NEOP is induced in monocyte and macrophages \nby cytokines such as interferon gamma (IFN-γ). And it is surmised to be as a reactive \nmarker of biocompatibility of dialysis membrane in hemodialyzed patients. \nIn this study, we evaluated the usefulness of serum NEOP as a marker for \nbiocompatibility of dialyzer by the use of E-membrane and control membrane in experimen- \ntal and clinical study. In experimental study in using dogs, exracorporal circulation with \nE-membrane and control membrane, the serial levels of serum NEOP in dogs using E- \nmembrane were lower than those of control membrane about the ratio of serum NEOP. In \nclinical study, during extracorporal ultrafiltration methods (ECUM), the levels of serum \nNEOP in patients using E-membranes were lower than those in patients using control \nmembranes. In long time evaluation of biocompatibility of there two membranes, the ratio \nof increasing of serum NEOP using control membranes was higher than that using E- \nmembranes. \nBy evaluation of serum NEOP for biocompatibility of membrane in dialysis, our observa- \ntion showed that serum NEOP is useful as a marker of biocompatibility in hemodialysis \nmembrane.
Cited by 0 works. doi:10.11501/3174504